BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 8610313)

  • 1. Ankle muscle activity before and after botulinum toxin therapy for lower limb extensor spasticity in chronic hemiparetic patients.
    Hesse S; Krajnik J; Luecke D; Jahnke MT; Gregoric M; Mauritz KH
    Stroke; 1996 Mar; 27(3):455-60. PubMed ID: 8610313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients.
    Hesse S; Lücke D; Malezic M; Bertelt C; Friedrich H; Gregoric M; Mauritz KH
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57(11):1321-4. PubMed ID: 7964805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term electrical stimulation enhances the effectiveness of Botulinum toxin in the treatment of lower limb spasticity in hemiparetic patients.
    Hesse S; Jahnke MT; Luecke D; Mauritz KH
    Neurosci Lett; 1995 Dec; 201(1):37-40. PubMed ID: 8830307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability and predictability of functional efficacy of botulinum toxin injection in leg spastic muscles.
    Rousseaux M; Compère S; Launay MJ; Kozlowski O
    J Neurol Sci; 2005 May; 232(1-2):51-7. PubMed ID: 15850582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change of stretch reflex threshold in spasticity: effect of botulinum toxin injections.
    Stampacchia G; Bradaschia E; Rossi B
    Arch Ital Biol; 2004 May; 142(3):265-73. PubMed ID: 15260380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrical stimulation of antagonist muscles after botulinum toxin type A for post-stroke spastic equinus foot. A randomized single-blind pilot study.
    Baricich A; Picelli A; Carda S; Smania N; Cisari C; Santamato A; de Sire A; Invernizzi M
    Ann Phys Rehabil Med; 2019 Jul; 62(4):214-219. PubMed ID: 31228593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How effective is physical therapy for gait muscle activity in hemiparetic patients who receive botulinum toxin injections?
    Fujita K; Miaki H; Hori H; Kobayashi Y; Nakagawa T
    Eur J Phys Rehabil Med; 2019 Feb; 55(1):8-18. PubMed ID: 29898587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin injection in patients with hereditary spastic paraparesis.
    Rousseaux M; Launay MJ; Kozlowski O; Daveluy W
    Eur J Neurol; 2007 Feb; 14(2):206-12. PubMed ID: 17250731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Botulinum A in the treatment of equinus dynamic spasticity in children with cerebral palsy. Preliminary study].
    Mousny M; Allington N
    Rev Chir Orthop Reparatrice Appar Mot; 1999 May; 85(2):156-63. PubMed ID: 10392416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contributions to the understanding of gait control.
    Simonsen EB
    Dan Med J; 2014 Apr; 61(4):B4823. PubMed ID: 24814597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there evidence that botulinum toxin injections are more effective than phenol injections in relieving poststroke reflex activity during plantar flexion, thereby increasing ankle range of motion and improving gait function?
    Cormack J; Powers CM
    Phys Ther; 2004 Jan; 84(1):76-84. PubMed ID: 14992678
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of spasticity with injections of botulinum toxin. Review of the literature].
    Fève A; Decq P; Filipetti P; Kéravel Y
    Neurochirurgie; 1998 Sep; 44(3):192-6. PubMed ID: 9827435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interest of peripheral anesthetic blocks as a diagnosis and prognosis tool in patients with spastic equinus foot: a clinical and electrophysiological study of the effects of block of nerve branches to the triceps surae muscle.
    Buffenoir K; Decq P; Lefaucheur JP
    Clin Neurophysiol; 2005 Jul; 116(7):1596-600. PubMed ID: 15905125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of spasticity in adults: practical application of botulinum toxin.
    Pathak MS; Nguyen HT; Graham HK; Moore AP
    Eur J Neurol; 2006 Feb; 13 Suppl 1():42-50. PubMed ID: 16417597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ankle and Foot Spasticity Patterns in Chronic Stroke Survivors with Abnormal Gait.
    Li S
    Toxins (Basel); 2020 Oct; 12(10):. PubMed ID: 33036356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study to investigate the combined use of Botulinum toxin type-a and ankle foot orthosis for the treatment of spastic foot in chronic hemiplegic patients.
    Pradon D; Hutin E; Khadir S; Taiar R; Genet F; Roche N
    Clin Biomech (Bristol, Avon); 2011 Oct; 26(8):867-72. PubMed ID: 21592635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automatic EMG-guided botulinum toxin treatment of spasticity.
    Finsterer J; Fuchs I; Mamoli B
    Clin Neuropharmacol; 1997 Jun; 20(3):195-203. PubMed ID: 9197941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose botulinum toxin with ankle taping for the treatment of spastic equinovarus foot after stroke.
    Reiter F; Danni M; Lagalla G; Ceravolo G; Provinciali L
    Arch Phys Med Rehabil; 1998 May; 79(5):532-5. PubMed ID: 9596394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin injection of spastic finger flexors in hemiplegic patients.
    Rodriquez AA; McGinn M; Chappell R
    Am J Phys Med Rehabil; 2000; 79(1):44-7. PubMed ID: 10678602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of muscle function in the spastic lower extremity.
    Perry J
    Clin Orthop Relat Res; 1993 Mar; (288):10-26. PubMed ID: 8458121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.